» Articles » PMID: 33046031

Development and Validation of the Cancer Symptoms Discrimination Scale: a Cross-sectional Survey of Students in Yunnan, China

Overview
Publisher Biomed Central
Specialty Critical Care
Date 2020 Oct 13
PMID 33046031
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study aimed to devise a Cancer symptoms Discrimination Scale (CSDS) suitable for China based on a cross-sectional survey.

Methods: The CSDS was developed using the classical measurement theory. A total of 3610 students from Yunnan province, China, participated in the cross-sectional survey. The test version of the scale was modified by the item analysis method, and after the official version of CSDS was developed, its reliability and validity were verified. A univariate analysis of variance and a multiple linear regression model were used to analyze the influencing factors of cancer symptoms discrimination among the university/college students.

Results: There were 21 items in total for the CSDS, including 3 subscales --- common clinical manifestations (11 items), physical appearance defects (6 items), and drainage tube(s) wearing (4 items). This CSDS had good validity (GFI = 0.930, AGFI = 0.905, RMR = 0.013, I-CVIs> 0.80, and the Pearson correlation coefficient was satisfactory.) and reliability (Cronbach's alpha = 0.862, spearman-brown coefficient = 0.875). The multiple linear regression showed that certain factors may affect the students' discrimination level against cancer symptoms (P < 0.05), including gender, major, current education degree, guardian's highest record of formal schooling, self-rated health status, history of care for cancer patients, family relationship, ways of cancer knowledge acquisition, good/poor understanding of cancer-related information, degree of cancer fear, and their perception of cancer infectiousness.

Conclusion: This CSDS, with good reliability and validity, can be used for the evaluation of the discrimination risk and levels against cancer symptoms among healthy students.

Citing Articles

Factors associated with shame and stigma among head and neck cancer patients: a cross-sectional study.

Peng H, Chen Y, Lee H, Tsai W, Chang Y, Lai Y Support Care Cancer. 2024; 32(6):357.

PMID: 38750287 DOI: 10.1007/s00520-024-08568-2.


Psychometric Characteristics of the Chinese Version of the Tuberculosis Related-Stigma Scale in a Population of Medical Students and Its Correlation with Selected Demographic Characteristics.

Yi Y, Sun M, Lu J, Dou X, Yu Y, Zhou L Risk Manag Healthc Policy. 2024; 17:815-826.

PMID: 38595754 PMC: 11003432. DOI: 10.2147/RMHP.S446068.


Cognition of the warning symptoms and risk factors for cancer among Chinese college students: a cross-sectional study based on a summer social practice activity.

Feng L, Li Q, Yang Q, Zhu Y, Yin F, Wang Q Ann Med. 2024; 55(2):2299574.

PMID: 38170847 PMC: 10769110. DOI: 10.1080/07853890.2023.2299574.


Development and reliability and validity test of the Fear of Cancer Scale (FOCS).

Feng L, Wu X, Li Q, Yang Q, Yin F, Wang Q Ann Med. 2022; 54(1):2354-2362.

PMID: 36066037 PMC: 9467598. DOI: 10.1080/07853890.2022.2113914.

References
1.
Hendriks J, Crijns H, Tieleman R, Vrijhoef H . The atrial fibrillation knowledge scale: development, validation and results. Int J Cardiol. 2013; 168(2):1422-8. DOI: 10.1016/j.ijcard.2012.12.047. View

2.
Saquib N, Pierce J, Saquib J, Flatt S, Natarajan L, Bardwell W . Poor physical health predicts time to additional breast cancer events and mortality in breast cancer survivors. Psychooncology. 2010; 20(3):252-9. PMC: 3297415. DOI: 10.1002/pon.1742. View

3.
Ettridge K, Bowden J, Chambers S, Smith D, Murphy M, Evans S . "Prostate cancer is far more hidden…": Perceptions of stigma, social isolation and help-seeking among men with prostate cancer. Eur J Cancer Care (Engl). 2017; 27(2):e12790. DOI: 10.1111/ecc.12790. View

4.
Feng L, Li X, Wang H, Zhan J, Chen D, Wang Y . Development and validation of the cancer self-perceived discrimination scale for Chinese cancer patients. Health Qual Life Outcomes. 2018; 16(1):165. PMC: 6092871. DOI: 10.1186/s12955-018-0984-x. View

5.
Ernst J, Mehnert A, Dietz A, Hornemann B, Esser P . Perceived stigmatization and its impact on quality of life - results from a large register-based study including breast, colon, prostate and lung cancer patients. BMC Cancer. 2017; 17(1):741. PMC: 5680772. DOI: 10.1186/s12885-017-3742-2. View